These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4473795)

  • 1. Proceedings: Drugs, mood, and amines: a profile in psychobiological research.
    Shopsin B; Friedman E; Gershon S; Goldstein M
    Psychopharmacol Bull; 1974 Oct; 10(4):52. PubMed ID: 4473795
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients.
    Shopsin B; Gershon S; Goldstein M; Friedman E; Wilk S
    Psychopharmacol Commun; 1975; 1(2):239-49. PubMed ID: 131359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of imipramine and synthesis inhibitors on biogenic amines.
    Friedman E; Shopsin B; Goldstein M; Gershon S
    J Pharm Pharmacol; 1974 Dec; 26(12):995-6. PubMed ID: 4156872
    [No Abstract]   [Full Text] [Related]  

  • 4. [Content, release and absorption of biogenic amines in CNS structures of the rat under the influence of sultones (proceedings)].
    Christl A; Fischer HD; Franz E; Funk K; Keller G; Rudolph E; Ruhnke M
    Pharmazie; 1979; 34(5-6):300-1. PubMed ID: 515127
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of drugs on amines in the CNS.
    Sulser F; Sanders-Bush E
    Annu Rev Pharmacol; 1971; 11():209-30. PubMed ID: 4948498
    [No Abstract]   [Full Text] [Related]  

  • 6. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
    Ridges AP
    Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
    [No Abstract]   [Full Text] [Related]  

  • 7. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the potential antidepressant AHR-1118 on amine uptake and on plasma 3-methoxy-4-hydroxyphenylglycol in manic-depressive illness [proceedings].
    Halaris AE; DeMet EM
    Psychopharmacol Bull; 1979 Apr; 15(2):95-7. PubMed ID: 432388
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of iprindole on amine uptake in man.
    Fann WE; Davis JM; Janowsky DS; Kaufmann JS; Griffith JD; Oates JA
    Arch Gen Psychiatry; 1972 Feb; 26(2):158-62. PubMed ID: 5060401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Different urinary excretion of 3-methoxy-4-hydroxyphenyl-glycol and response to tricyclic antidepressive drugs].
    Beckmann H; Jones C; Goodwin FK
    Arzneimittelforschung; 1974 Jul; 24(7):1010-2. PubMed ID: 4408047
    [No Abstract]   [Full Text] [Related]  

  • 12. Affective disorders and norepinephrine pharmacology.
    Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
    Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
    [No Abstract]   [Full Text] [Related]  

  • 13. Is urinary MHPG a real predictor of drug response in primary depression?
    Cazzulo CL; Sacchetti E; Allaria E; Motta A; Conte G; Gasperini M; Smeraldi E
    Adv Biochem Psychopharmacol; 1982; 32():237-47. PubMed ID: 7090894
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Ptosis as a model of depression.
    Tedeschi DH; Boshek RL; Boston JE
    Psychopharmacol Bull; 1974 Oct; 10(4):21-2. PubMed ID: 4473794
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Amine depletion as an experimental approach to the aminergic hypothesis.
    Mendels J
    Psychopharmacol Bull; 1974 Oct; 10(4):54-6. PubMed ID: 4279415
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action mechanism of antidepressive drugs. Review of current knowledge].
    Panichi C; Faravelli C
    Riv Patol Nerv Ment; 1984; 105(6):249-82. PubMed ID: 6100975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological studies of mood disorders.
    Schildkraut JJ
    Proc Annu Meet Am Psychopathol Assoc; 1972; 60():65-92. PubMed ID: 4551137
    [No Abstract]   [Full Text] [Related]  

  • 18. 3H-imipramine and 3H-desipramine binding sites in depression.
    Langer SZ; Raisman R; Sechter D; Gay C; Loo H; Zarifian E
    Adv Biochem Psychopharmacol; 1984; 39():113-25. PubMed ID: 6380221
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Norepinephrine metabolism in subtypes of depressive disorders.
    Schildkraut JJ
    Psychopharmacol Bull; 1974 Oct; 10(4):49-50. PubMed ID: 4431872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biogenic amines and effective disorders (author's transl)].
    Takahashi R
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1798-808. PubMed ID: 6171015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.